Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.

BACKGROUND & AIMS Genomic instability in colon cancers is a consequence of chromosomal instability characterized by aneuploidy or defective DNA mismatch repair (MMR) indicated by microsatellite instability (MSI). Given that high-frequency MSI (MSI-H) and diploidy are correlated, we determined whether they are independent prognostic variables. METHODS Astler-Coller stage B2 and C colon cancers (N = 528) from patients treated in 5-fluorouracil-based adjuvant therapy trials were analyzed for MSI using 11 microsatellite markers. Immunostaining for hMLH1, hMSH2, and p53 proteins was performed. DNA ploidy was analyzed by flow cytometry. Associations with disease-free and overall survival were determined. RESULTS MSI-H was detected in 95 tumors (18%), and 70 (74%) of these were diploid. Tumors showing MSI-H (hazard ratio, 0.65; 95% confidence interval, 0.44-0.96; P = .023) or loss of MMR proteins (P = .024) were associated with better overall survival. Improved disease-free and overall survival were found for diploid versus aneuploid/tetraploid tumors (overall survival: hazard ratio, 0.59; 95% confidence interval, 0.43-0.79; P = .0003). In the subgroups of MSI-H and microsatellite stable (MSS)/low-frequency MSI (MSI-L) tumors, diploidy was associated with better survival. The prognostic impact of ploidy was similar in stage B2 and C tumors. Ploidy did not predict the benefit of 5-fluorouracil-based treatment. When ploidy, MSI, and MMR proteins were analyzed in the same multivariate model, only ploidy remained significant. CONCLUSIONS DNA ploidy and MSI-H status were independent prognostic variables, yet ploidy was the strongest marker. Diploidy was associated with better survival in MSI-H and in MSS/MSI-L patient subgroups.

[1]  D. Sargent,et al.  Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Wolff,et al.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.

[3]  S. Kakar,et al.  Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival , 2004, Modern Pathology.

[4]  B. Iacopetta,et al.  CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Daniel J Sargent,et al.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. , 2003, The New England journal of medicine.

[6]  C. Compton,et al.  Characterization of sporadic colon cancer by patterns of genomic instability. , 2003, Cancer research.

[7]  W. Lingle,et al.  Centrosome amplification and the development of cancer , 2002, Oncogene.

[8]  M. Leppert,et al.  Prognostic significance of p53 mutations in colon cancer at the population level , 2002, International journal of cancer.

[9]  D. Sargent,et al.  Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Sargent,et al.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Herman,et al.  Low-level microsatellite instability in most colorectal carcinomas. , 2002, Cancer research.

[12]  D. Schaid,et al.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. , 2001, American journal of human genetics.

[13]  L. Aaltonen,et al.  Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. , 2000, Gastroenterology.

[14]  M. Perucho,et al.  Late onset and high incidence of colon cancer of the mutator phenotype with hypermethylated hMLH1 gene in women. , 2000, Gastroenterology.

[15]  A. de la Chapelle,et al.  Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. , 2000, The American journal of pathology.

[16]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[17]  S. Bull,et al.  Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. , 2000, The New England journal of medicine.

[18]  B. Iacopetta,et al.  p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma , 2000, Oncology.

[19]  K. Endo,et al.  Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma , 1999, Cancer.

[20]  L. Aaltonen,et al.  Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Schaid,et al.  Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. , 1999, Journal of the National Cancer Institute.

[22]  F. Sinicrope,et al.  Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  C. Boland,et al.  Mismatch repair proficiency and in vitro response to 5-fluorouracil. , 1999, Gastroenterology.

[24]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[25]  S N Thibodeau,et al.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. , 1998, Cancer research.

[26]  D. Schaid,et al.  Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.

[27]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[28]  A. Børresen-Dale,et al.  Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors , 1997, International journal of cancer.

[29]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[30]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[31]  L. Aaltonen,et al.  Better survival rates in patients with MLH1-associated hereditary colorectal cancer. , 1996, Gastroenterology.

[32]  A. Rustgi,et al.  DNA mismatch repair and cancer. , 1995, Gastroenterology.

[33]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[34]  B. Vogelstein,et al.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. , 1994, The American journal of pathology.

[35]  L. Aaltonen,et al.  Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. , 1993, Cancer research.

[36]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[37]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[38]  H. Wieand,et al.  DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma , 1991, Cancer.

[39]  J. Hardcastle,et al.  The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis. , 1990, British Journal of Cancer.

[40]  S. Cha,et al.  Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. , 1987, Archives of surgery.

[41]  J. Arends,et al.  Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. , 1987, Cancer research.

[42]  J. Chmiel,et al.  Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[43]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[44]  F. A. Coller,et al.  THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.

[45]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[46]  W. Bodmer,et al.  Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. , 2002, Cancer research.

[47]  R. Gafà,et al.  Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma , 1998, Cancer.

[48]  D. Cox.  Regression Models and Life-Tables , 1972 .